F ocal atrial tachycardia (FAT) is a relatively uncommon form of supraventricular tachycardia that is difficult to treat with antiarrhythmic drugs (AADs). However, with the advent of radiofrequency catheter ablation (CA), this tachycardia can be treated with a high long-term success rate. [1] [2] [3] The key aspect of successful ablation is to localize the site of the earliest site with and without 3-dimensional (3D) mapping techniques during tachycardia. Although activation mapping remains the cornerstone for identifying the tachycardia origin, the initial P wave morphological information can facilitate ablation procedure. Several P wave algorithms have been developed to identify the origin of tachycardia in most patients with sustained tachycardia. [4] [5] [6] [7] [8] However, these algorithms may misidentify the FAT origins in patients with diseased atrial muscles or previous linear lesions because of CA or a surgical operation. Furthermore, it is clinically difficult to map and ablate difficult-to-induce and nonsustained FAT with and without intravenous administration of isoproterenol during ablation. Pace mapping (PM) is generally used to identify ventricular arrhythmia origin and can clinically be highly successful in patients with infrequent ventricular arrhythmias. However, whether the FAT origin can be identified using PM of the atria is unknown. In this study, we aimed to identify the FAT origin using paced P wave morphology and intracardiac activation sequence on 3D mapping during PM in patients with difficult-to-induce and nonsustained FAT. Pace Mapping and Focal Atrial Tachycardia Origin drug-refractory, and nonsustained type with a distinct P wave morphology and frequent daily episodes on Holter electrocardiography (ECG; Figure 1A ) and ablated using only PM. In other 107/114 (93.9%) patients, activation mapping was used to guide ablation procedure. All 7 patients had structurally normal hearts as documented by echocardiographic evaluation. Previous ablation was documented in 5 patients, including failed FAT ablation in 1 patient, slow pathway ablation for atrioventricular nodal reentrant tachycardia in 2 patients at another center, and circumferential pulmonary vein isolation (PVI) because of the misdiagnosis of atrial fibrillation based on irregular heart rate on Holter ECG in the remaining 2 patients. The present study is a retrospective analysis and was approved by the local ethics committee.
Electrophysiology Study
AADs were discontinued ≥5 half-lives before CA. All patients provided written informed consent to undergo an electrophysiological study in the fasting state: 5 under mild sedation and 2 without sedation. Two 8-pole catheters with interelectrode space (the initial part of 2-10-2 mm, the remaining part of 5 mm) were positioned in the coronary sinus (CS) and at the His-bundle area. When pulmonary veins (PVs) were suspected to be the FAT origin, an additional 10-pole circular mapping catheter was inserted into the PV through an 8.5-F long sheath (SL1) using the modified Brockenbrough technique. Twelvelead surface ECGs and intracardiac electrograms were recorded simultaneously using a digital multichannel system (EP-WorkMate; St Jude Medical, St Paul, MN) and filtered at 30 to 500 Hz for bipolar and at 0.05 to 500 Hz for unipolar electrograms. If clinical arrhythmias failed to occur spontaneously, programmed stimulation was performed at 2 basic drive cycle lengths (CLs) with 2 extra stimuli until the refractory period and burst pacing with a shortest CL of 230 ms at the right atrium (RA) and proximal of CS. If clinical arrhythmia was not inducible at baseline, intravenous isoproterenol infusion (1-4 μg/min) and interruption of sedation were administered to provoke clinical arrhythmias. The P wave morphology on surface 12-lead ECG and intracardiac atrial activation sequence recording from >2 catheters during spontaneous or induced nonsustained FAT were analyzed.
3D Electroanatomical Mapping and PM
Anatomic reconstruction of the atrium was initially performed using a 3D electroanatomical mapping system (CARTO; Biosense Webster, Diamond Bar, CA) during sinus rhythm. Mapping in both atria was performed using a 7.5-F D-curve catheter with a 3.5-mm open-irrigated-tip electrode (Navistar ThermoCool catheter with unidirectional curve; Biosense Webster). The paced P wave morphology and intracardiac atrial activation sequence were compared with those during AT. Bipolar PM was systematically performed at the areas of interest based on the algorithm of P wave morphology of the tachycardia on surface ECG. 5, 6 Later, we paced the expected area and surrounding area according to specific structure (eg, PV, CS, mitral annulus, tricuspid annulus, and crista terminalis). If one of them obtained a good paced match of the P wave and atrial activation sequence, denser PM was performed close to the good paced match site to obtain best-paced match site. The sites with PM were tagged and labeled on the CARTO map. PM was always performed with minimal output (voltage, 2-10 mV; pulse duration, 0.5-2 ms) and CL similar to clinical AT-CL to avoid far-field capture of adjacent structures, which can result in variations of paced P wave morphology or atrial activation sequence because of conduction delay. P wave morphology on 12-lead ECG was assessed as previously described. 5, 6 The P wave analysis was performed during periods of atrioventricular block or long pause after ventricular pacing at a paper speed of 50 mm/s. P wave morphology in the 12-lead ECG was matched manually by 2 trained electrophysiologists. P waves were described based on the deviation from baseline during the T-P interval as (1) positive if there was a positive deflection from the isoelectric baseline, (2) negative if there was negative deflection, (3) biphasic if there were both positive and negative deflections from baseline, and (4) flat if there were no deflections from baseline. We attempted to match the captured P wave morphology at each site during pacing with the P wave morphology during clinical AT as assessed from P wave configurations, amplitude, and duration. Additionally, the intracardiac atrial activation timing and activation sequence recording from multiple catheters during AT and atrial pacing were measured, and deviations between AT and atrial pacing were compared at every paced site. Briefly, the activation time and sequence were recorded from >2 diagnostic catheters, which were stably positioned at the His region, CS, and in some cases, within the PV (eg, time between atrial recording in the proximal His bundle and distal CS). A stable reference from distal CS was used to measure the intracardiac atrial activation time and the sequence of atrial depolarization during tachycardia and PM, which was performed using the ablation catheter with minimal output and CL similar to clinical AT-CL. We paid attention to not only activation sequence and time interval between 2 catheters but also the morphology and polarity of bipolar potential in diagnostic catheter manually to improve diagnostic performance. The best-paced site was defined as the paced P wave, and the paced intracardiac activation sequences were identical/similar to those during AT.
Radiofrequency CA
CA in both atria was performed using the catheter with a 3.5-mm open-irrigated-tip electrode (Navistar ThermoCool; Biosense Webster) in combination with RF generator (Biosense Stockert 70; Stocker GmbH, Freiburg, Germany). The CA target of FAT origin was defined as best-paced site if the tachycardia was not inducible within 30 minutes. Focal ablation was delivered at the origin in patients with non-PV FAT or at the conduction gap in patients with previous circumferential PVI. Circumferential ablation was performed in patients with FAT originated from PV and without previous PVI. In patients with PV FAT, the ablation end point was complete PV antrum isolation with entrance and exit block. Irrigated radiofrequency energy was delivered with a target temperature of 45°C, maximal power limit of 30 W, and an infusion rate of 20 mL/min. After successful ablation, intravenous administration of isoproterenol and pacing maneuvers were repeated to reinduce clinical ATs.
Acute success was defined as (1) absence of spontaneous or provoked clinical AT at the end of the procedure and (2) absence of the atrial tachyarrhythmia on 48-hour postablation ECG monitoring without AADs.
Statistical Analysis
Continuous variables are presented as mean±SD, whereas categorical values are presented as absolute values and percentages. Only descriptive statistics are provided.
WHAT IS KNOWN
• Focal atrial tachycardia is extremely difficult to map and ablate when it is difficult to induce and nonsustained.
• Pace mapping is commonly used in patients with ventricular arrhythmias; however, the origin of focal atrial tachycardia is rarely identified only by pace mapping because activation mapping in conjunction with pace mapping has usually been used.
WHAT THE STUDY ADDS
• Pace mapping may be useful for identifying the focal atrial tachycardia origins by matching P wave morphology and intracardiac atrial activation sequence.
• This maneuver can be used for patients with difficult-to-induce and nonsustained focal atrial tachycardia to improve clinical outcome. Pace Mapping and Focal Atrial Tachycardia Origin 
Results

Clinical and Electrophysiological Characteristics
Clinical symptoms were palpitation in 5 patients and exercise-induced dyspnea in 2 patients. Continuous recording of 24-hour ECG showed daily attacks in 3 patients ( Figure 1A , patient no 2). All patients were refractory to 1 to 3 AADs.
FAT was induced with difficulty in all 7 patients. Tachycardia was not initiated by atrial programmed pacing, and all patients required isoproterenol infusion to induce tachycardia, which presented as nonsustained AT with a variable CL in all 7 patients ( Figure 1B , patient no 2 and Table 1 ). A discrete P wave was observed on 12-lead ECG in all 7 patients. The clinical and P wave characteristics in 12-lead ECG are shown in Table 1 , and the electrophysiological characteristics of clinical FAT are shown in Table 2 .
Paced P Wave Morphology and Intracardiac Activation Sequences
Anatomic mapping was successfully achieved with a mean of 56.9±20.2 points. An area of low amplitude (<0.5 mV) in left atrium (LA) was found in patients no 5 and no 7, respectively, with 1 patient previously having undergone circumferential PVI. Based on P wave morphology, PM was performed at 5 to 16 sites during LA FAT and in 8 to 17 sites during RA FAT. PM obtained best-matched P wave morphology on 12-lead ECG in 12/12 leads in 2 patients, 11/12 in 4 patients, and 11/11 in 1 patient because of noise on the precordial V5 lead.
In 3 patients (patients no 1, no 2, and no 6) with non-PV FAT, the induced tachycardias had maximal durations of 10 s (3-10 s). PM in the area of interest identified the best-paced site at the superior crista terminalis (patient no 1), anterior mitral annulus (patient no 2), and inferior-lateral tricuspid annulus (patient no 6). No low-voltage area in the atrium area of interest was found in these 3 patients. At the bestpaced site, the paced P wave morphology of 12-lead ECG was matched to the clinical P wave morphology in 11/12 leads (patient no 1; Figure 2A and patient no 6) and 11/11 leads (patient no 2; Figure 3A ). No significant delay from stimulus to P wave onset was observed in these 3 patients. Paced intracardiac activation sequence obtained from His and CS catheter was the same as the sequence of the clinical FAT, and no deviation from the clinical tachycardia was observed ( Figures 2B and 3B ). After extensive mapping, FAT was not induced in all 3 patients in whom the earliest activation preceding the P wave onset during clinical AT could not be evaluated.
In 4 patients with PV origin (patients no 3-5 and no 7), the induced tachycardias had a maximal duration of 5 s (2-5 s). In 3 patients without previous circumferential PVI, PM in LA revealed that the best-paced match was at the anterior ostium of the right inferior PV (patient no 3), posterior ostium of the right superior PV (patient no 4), and inferior ostium of . At the best-paced site, the paced P wave morphology on 12-lead ECG was matched to the clinical P wave morphology in 12/12 leads (patient no 7) and in 11/12 leads (patients no 3 and no 4; Figure 4A ); no significant delay from stimulus to P wave onset was observed. Paced intracardiac activation sequence obtained from CS and His/PV catheter was the same as the sequence of the clinical FAT, and the deviation from the clinical tachycardia was 0 ms in all 3 patients ( Figure 4B ). In patient no 5 with previous PVI, pacing within the right superior PV and at the conduction gap located in the middle of the previous posterior linear lesion demonstrated the best match to the clinical P wave morphology. No significant delay from stimulus to P wave onset was observed by pacing at the conduction gap, whereas a long delay from stimulus to P wave onset (140 ms) on pacing from the Lasso catheter within the right superior PV was shown ( Figure 5 ).
The P wave morphology of the anterior right inferior PV origin (patient no 3) was biphasic (positive-negative) in lead V1 and flat in lead aVL, whereas in 3 patients with right-sided posterior and inferior PV origin (patients no 4, no 5, and no 7), the P wave during tachycardia and PM demonstrated a clear M wave (bifid positive) in lead V1 and a biphasic (positivenegative) P wave in lead aVL (patient no 4), flat-positive P wave in lead aVL (patient no 5), and negative P wave in aVL (patient no 7).
The mean PM time during the procedure was 26.9±5.7 minutes. After identifying the best-paced site, a nonsustained FAT with a maximal duration of 2 s was induced only in patients no 3 and no 4. The earliest local activation was found at the best-paced site and preceded the P wave onset by 40 ms (patient no 3) and 25 ms (patient no 4).
Not lower than 11/12 P wave-paced match identified FAT origins with a sensitivity of 100% and specificity of 100%. The deviation of paced intracardiac activation sequence from the clinical tachycardia of <5 ms identified FAT origins with a sensitivity of 100% and specificity of 78%.
The minimal distance between the best-paced match site and the site with at least 1 lead different paced P wave morphology measured in the 3D mapping system was 9 to 13 mm in each patient.
CA and Follow-Up
In the 3 patients with non-PV origin (patients no 1, no 2, and no 6), 2 or 3 radiofrequency applications with a total duration of 180 to 240 s were delivered at the best-paced site because of noninducibility after extensive mapping. Radiofrequencyassociated response occurred only in patient no 1 in whom the radiofrequency ablation-induced tachycardia with a fast CL, similar P wave, and atrial activation suddenly disappeared 6 s after ablation.
In 3 patients with PV origin and without previous PVI (patients no 3, no 4, and no 7), circumferential RPVI was performed. A total of 9 to 12 RF applications with 610 to 820 s resulted in complete PVI with entrance and exit block. In 1 patient with previous PVI (patient no 5), a single radiofrequency application with a duration of 120 s was delivered at the conduction gap and resulted in complete electric isolation of RPV. Nonconducted PV tachycardia from variable CL within the isolated PVs was observed during radiofrequency ablation in these 4 patients.
The mean procedure time and fluoroscopy time was 110±13.8 and 5.9±5.4 minutes, respectively. The cumulative delivered energy was 5732 to 6970 J in patients with non-PV origin FAT, 21 342 to 27 342 J in patients with PV-origin FAT, and 3538 J in patient with FAT because of conduction gap of PVI.
No FATs were induced at the end of the procedure even using isoproterenol infusion and pacing maneuvers, and no complications occurred. There were no AT-associated symptoms and no evidence of atrial arrhythmias on multiple recordings from surface ECG (3-6 times) and three 24-hour Holter ECG. All patients were free of arrhythmias without AADs during the follow-up of 8.4±5.6 months.
Discussion
The basic prerequisite for FAT ablation is to identify the earliest site of intracardiac activation using conventional or 3D mapping techniques. However, it is clinically difficult to map and ablate difficult-to-induce and nonsustained FAT with and without the intravenous administration of isoproterenol. Furthermore, mechanical interruption by endocardial catheters occasionally causes tachycardia suppression. 9 The P wave algorithm clinically facilitates localization of the tachycardia origin in patients with normal hearts, 4-8 but it is occasionally inaccurate. Our PM method may complement the weakness of P wave algorithm and provide some clinical implication and usefulness for specific patients.
P Wave Morphology in 12-Lead ECG and Distribution of FAT
FAT origins in RA occur along crista terminalis, 10 tricuspid annulus, 11 the ostium of CS, 12 and the perinodal region. In LA, origins occur predominantly at the PV ostia 4, 7, 13 and mitral annulus 7, 14 and less commonly in the LA appendage 15 and left-sided septum. The specific anatomic location can provide a unique P wave on 12-lead ECG. Leads aVL and V1 have been described as the best for distinguishing between LA and RA foci, 5, 6, 16 ) , which is incompatible with Kistler's algorithm that the P wave in V1 showed monofid-positive P wave in V1 on surface ECG. The activation sequence of FAT from posterior RPV is different compared with that from anterior RPV. Kistler's study probably included many patients with FAT from anterior RPV; therefore, the P wave of our patients did not fit into his algorithm, and our study included 3 posterior RPV FAT. The difference from Kistler's algorithm can be explained: (1) FAT from RPV mostly originates from the anterior wall of RPV, which simultaneously (2) the origin from posterior wall of RPVs propagate from LA posterior wall to LA anterior wall and then propagate to RA, which creates a bifid-positive morphology in V1 in our patients. Additionally, in 3 patients with FAT from posterior antrum of the right-sided PV, bifid P wave in V1 was similar to that originating from the left-sided PVs. However, polarity of the P wave in lead I can differentiate them. Furthermore, the P wave algorithm developed by Tang et al also was compatible in 4/7 patients. These algorithms are based on the normal atrial muscle. However, in cases of low-voltage or conduction block areas in the atrium because of CA or surgical operation, the conduction sequence in the atrium differs from that of the normal heart.
P Wave and Intracardiac Activation Sequence During PM
PM of P waves is difficult because of the low P wave amplitude and superimposition of the P wave on T wave during tachycardia. We could evaluate the P waves preceded by an isoelectric baseline because of variable CL during clinical tachycardia in all cases. Selvaraj et al reported the accuracy of manual P wave PM. 17 They indicated that paced match score at the same paced site was 11.5±0.6 out of 12 for the 12-lead ECG evaluated by blinded observer. This result supports P wave pacing methodology.
Man et al. 18 assessed the spatial resolution of P wave morphology using unipolar atrial PM at different CS and RA-free wall sites. They demonstrated that only subtle changes in P wave morphology occur when atrial pacing sites are 11 to 17 mm apart. In another study, the spatial resolution of PM in atrium using unipolar pacing was 9.9 mm. 17 Although significant changes in P wave amplitude and duration can be detected, the magnitudes are small and often visually indiscernible. However, FAT usually originates from particular complex structures (eg, crista terminalis, PVs, CS ostium, and around the annulus). P wave configuration could easily vary in these areas because of the complexity of atrial conduction from FAT origins relative to that of uniform structures, as mentioned in previous reports (eg, the CS middle part and RA-free wall). Bipolar PM with minimal output showed different P wave morphologies within 9 to 13 mm between nonuniform structures and provided a useful supplementary guide to the location of the FAT origin (Figures 2A-4A ). Kadish 19 They indicated that only minor QRS configuration differences (0.5±1.2 leads) between unipolar and bipolar pacing occurred when the interelectrode distance during bipolar pacing was 5 mm; however, when the interelectrode distance was 10 mm, this difference was more obvious (1.3±2.0 leads). We used mapping catheter with 2-mm interelectrode distance for bipolar pacing; therefore, bipolar pacing in our study resulted in similar spatial resolution compared with unipolar pacing reported previously.
However, to complement the spatial limitations of P wave PM, more information about atrial activation sequence during PM is required. Paced intracardiac activation sequence in combination with P wave PM may be helpful to complete difficult-to-induce and nonsustained FAT localization. Tracy et al used a paced intracardiac activation sequence and compared the activation sequence at multiple atrial sites during spontaneous tachycardia with that recorded using multiple catheters and the ablation catheter. 1 Using this technique and activation mapping, Tracy et al reported a success rate of 80% without 3D mapping, wherein significantly less deviation from the spontaneous activation sequences occurred (2±2 ms, range: 0-5) at the sites of successful energy delivery relative to that at the sites of unsuccessful energy delivery. The matched paced intracardiac activation sequence correlated with the earlier activation time recorded using the ablation catheter that preceded the earliest intracardiac atrial activation or the earliest surface ECG P wave. Ju et al reported mapping of FAT or localized reentry of tachycardia with a chaotic activation map because of intra-atrial conduction delay after extensive atrial ablation. 20 Santangeli et al reported that analysis of implantable cardioverter defibrillator electrogram morphology with pacing around the edge of the scar was unable to distinguish distinct ventricular tachycardia exit sites spaced <2 cm apart. 21 These 2 reports indicate the difficulty in evaluation of P wave and intracardiac activation sequences during PM with diseased atrial muscle. We always tried to pace with minimal output and CL similar to clinical AT to avoid far-field capture and increment of intra-atrial conduction delay. Theoretically, the PM method is available in patients with diseased atrial muscle. However, in our study, only 2 patients with large scar areas in LA were included, and both were FAT from PV. Therefore, further evaluation is required to verify this method in patients with low-voltage areas and FAT originating from outside PV. In our patients with previous circumferential PVI, PM at the conduction gap and within the RPVs demonstrated the same P wave ( Figure 5 ) and identical activation sequence. This technique can help identify the recovered conduction across the previous wide circumferential PVI and facilitate ablation procedure of difficult-to-induce AT because of focal tachycardia from PV.
CA of FAT
Previous studies have demonstrated that a noncontact mapping system could be used for mapping and ablating nonsustained FAT. 22, 23 However, the noncontact mapping system is highly dependent on the anatomic distance between the origin and balloon location. Moreover, interpretation of virtual noncontact electrograms is difficult and may be influenced by individual investigators. Completion of mapping is impossible if clinical AT cannot be induced after positioning of the system in the atrium area of interest. In our study, P wave PM and paced intracardiac activation sequence mapping can solve these problems. It was further supported with clinical outcome during follow-up in our patients with frequent nonsustained FAT.
Limitations
This study had several limitations. First, a major limitation of this study was the small number of enrolled patients (6.1% of focal AT) because we used the pacing maneuver only for a subset of patients with difficult-to-induce and nonsustained AT. In particular, the utility of PM in patients with structural atrial disease remains to be determined and should be verified in a larger number of patients for generalized application. Second, because of lack of specific software to evaluate P wave morphology (eg, PaSo module; Biosense Webster or EnSite Precision software; St Jude Medical), qualitative measurement of P wave morphology was systematically performed. A much larger number of patients or more precise quantitative analysis is needed to verify this technique. However, the clinical results of successful ablation in all patients are encouraging. Third, in keeping with the known spatial limitations of P wave PM, anatomic sites in close proximity may be more difficult. Therefore, patients with difficult-to-induce tachycardia theoretically require a relatively wide ablation area. However, only a few radiofrequency applications can eliminate clinical ATs in patients with non-PV origins in clinical practice. Finally, P wave PM cannot be used if the P wave is unclear, despite using vagal maneuver, infusion of adenosine, or termination of ventricular pacing.
Conclusions
PM may be useful for identifying the FAT origins by matching P wave morphology and intracardiac atrial activation sequence. This maneuver can be used for patients with difficult-to-induce and nonsustained FAT.
